| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Name (English - Chinese, eg, Liang He - 贺亮) | How long you have been in service in CABS? | Prior CABS Service? (eg, AMC, O2, PRC etc.) | Which Committee you want to service this year? | Title and Affiliation | URL of LinkedIn page | Bio (<200 words) | Election Statement (<200 words) | ||||||||
2 | Shicheng Guo - 郭士成 | 1 years | O2 | Director, Arrowhead Pharmaceuticals | https://www.linkedin.com/in/shg047/ | Shicheng Guo is the Director of Translational Genetics and Clinical Pharmacology at Arrowhead Pharmaceuticals. He earned his Ph.D. in Life Sciences from Fudan University in China. He was previously a Principal Scientist at Janssen Research and Development where he led projects applying computational biology and machine learning to drug discovery and development. He has over 13 years of experience in statistical genetics, bioinformatics, pharmacogenetics, and computational biology. He has authored over 100 publications and over 200 reviews. His work focuses on genome-wide association studies, next-generation sequencing, and multi-omics data analysis to determine genotype-phenotype relationships and identify biomarkers. He is skilled in statistical methodology development and application, as well as machine learning techniques like neural networks for prediction modeling. He is proficient in programming languages like R, Perl, Python, and Linux. | Bringing deep expertise in data science and analytics to enhance CABS' operations, growth, and member value. Eager to apply advanced data techniques to optimize events, promotions, surveys, and leverage technology to modernize the website, database, and decision-making. Committed to maximizing efficiency and impact through an innovation mindset. | |||||||||
3 | Liang He - 贺亮 | 2 years | Liang has served as a volunteer of PRC (2022), and most recently AMC (2022) since he joined CABS in 2021. He served as the cochair of PRC(2023). He actively served on the Organizing Committee of the 2022/2023 BioPacific Conference. | research scientist， UCSF | linkedin.com/in/liang-he-b646baa4 | Dr. Liang He is a postdoc at UCSF. Liang received his Ph.D. from the Institute of Biophysics, University of Chinese Academy of Science, and doing his postdoctoral training at the Department of Cellular Molecular Pharmacology, UCSF. He has over 10 years of virology study experience focusing on virus and host interaction, aiming to inhibit emerging virus replication. Liang utilizes molecular biochemistry, immunology, and cell biology method to study how the host factors inhibit the virus lifecycle. Now he is developing new methods/systems to better study virology at UCSF, using biosensors/reporters, and animal models of diseases. In his spare time, He likes running, hiking, playing basketball, and biking. | service, is always making things working well. | |||||||||
4 | Mark Wesson MPH FACHE | 0 years | Chief Executive Officer, SCI Americas | Mark Wesson is a highly skilled career healthcare services and research program professional turned venture partner with the skills, insights, acumen, and recommendations to scout and build early-stage HealthTech companies. He is also adept at identifying truly innovative HealthTech investment opportunities that are well positioned for product-market fit, verifiable need on a sustainable path to growth, and identification or creation of blue ocean opportunities. He assists companies in achieving a broader market appeal using product, customer, partner, or innovative adjacencies not previously considered. Throughout his career, he has found and applied new and more effective ways of ensuring high-quality patient care. To do that, he relies daily on remaining informed about the latest leadership and technology news. Mark provides consulting services to help mergers and acquisitions, private equity, venture capital, healthcare services, and technologies companies optimize their market success throughout the corporate and product life cycles. He conducts complete business analytics to identify areas that impact quality, operational excellence, identify systemic or process impediments to success, and adaptation of company/product proposed or active business models to more or new relevant market(s) and/or segment(s). Mark advises clients and startups on product and market strategy, emerging technologies and strategic and policy directions, and innovative problem-solving methods to assure a future-facing and agile path to success. He provides these services as an independent consultant; through several startup accelerators as a Mentor; and through online advisory platforms. He is the Principal Consultant at Healthcare Development Consultancy, a reviewer for three academic journals, has been invited as a judge for startup competitions, thrives on bringing notice to true innovations that achieve lowering cost, increasing access, and maximizing quality in all of his work. Please feel free at anytime to email him at wesma31@gmail.com or mark@sci-am.com. | ||||||||||||
5 | Yanan Wang - 王亚男 | 1.5 years | AMC | QLSF Biotherapeutics, Senior Scientist | https://www.linkedin.com/in/yanan-wang-a51779b4/ | I am currently a Senior Scientist at QLSF Biotherapeutics. I received my Ph.D. from Shanghai Jiao Tong University in Shanghai, China in 2015, and completed postdoctoral training at Fudan University in 2018 and Stanford University in 2020. After postdoc, I joined Ab Studio as a Scientist and focused on therapeutic antibody discovery and assay development. | I would like to contribute to build a better CABS community. | |||||||||
6 | Guanghui Han - 韩广辉 | yes | PRC | Head of Proteomics, PTM Bio LLC | https://www.linkedin.com/in/guanghui-han-5001723b/ | Dr. Han received his post-doctoral training at Johns Hopkins School of Medicine in Dr. Gerald Hart’s group. His research was focused on understanding the role of O-GlcNAcylation in disease, a modification discovered in the Hart lab, and specifically worked on methods for enrichment and detection of the modification in kinases and their roles in the crosstalk between glycosylation and phosphorylation. In 2014, Dr. Han joined Genentech Inc, where his role as a scientific manager was to develop and apply MS based technologies for characterization of therapeutic molecules. In 2018, Dr. Han helped found the Mass Spectrometry Center in San Jose at BGI Americas Corporation as the Senior Director. Currently, Dr Han is the Head of Proteomics at PTM Bio LLC, which provides high quality Proteomics service with a special focus on the PTMs (Post Translational Modifications) to accelerate drug R&D with by using state-of-the-art Mass Spectrometers. Dr. Guanghui Han has published more than 40 papers in a variety of international journals, including Nature, Molecular cell, Molecular & Cellular Proteomics, Analytical Chemistry, mAbs, with over 3600 citations. | After changing to my new job, should have more time this year to volunteer at CABS | |||||||||
7 | Sihong Zhou 周思红 | 11 years | O2, SLC | Senior scientist, Sutro | https://www.linkedin.com/in/sihong-zhou-0a5550b/ | I graduated from Shanghai Medical University. I have been working as a senior scientist in Sutro biopharma in the past 9 years. I'm experience in cell-based assay development, biochemical assay development, HTS, target validation from early drug discovery to late stage of assay validation. I have been served at CABS over 10 years and currently holding operational office Co-chair position. | I've been serviced at CABS as a operational office chair, co-chair and SLC co-chair for near 10 years. I've gained good amount of experience on how to support president to operate the organization and how to organize different events. I sincerely hope to continue to support CABS and the president in the next term. And I believe what I gained in CABS will be great rewarding for me personally and professionally. In the coming year, I can take more initiatives to better serve biopharmaceutical professionals, and to promote CABS to a higher level locally and internationally. | |||||||||
8 | Wenjia Gu - 顾文嘉 | 2 years | Membership | Associate Scientist, Sutro Biopharma | https://www.linkedin.com/in/wenjiagu/ | Wenjia Gu currently works at Sutro Biopharma as a scientist. She obtained her bachelor’s degree from Zhejiang University and her Ph.D. from the University of Utah. She has 10 years of academic and industry experience in protein biochemistry, protein engineering, synthetic biology, and analytical chemistry. She has authored 11 publications, including being the first author in JACS. Before joining Sutro, she worked as a scientist at Zymergen. Currently, she serves as the 2023 Membership Co-chair for CABS. | It is my great pleasure to seek re-election as an EC member for CABS. Over the past two years of service at CABS, I led the Speaker Interview team for the 2022 BioPacific Conference, served as the 2023 co-chair of Membership, and co-led the volunteer organization for the 2023 CABS 25th-anniversary reception and the 2023 CABS BioPacific Conference. Additionally, I have actively participated in many CABS events, enjoying the experience of organizing them with fellow members and forming valuable connections. In this new term, I aspire to continue my efforts and contribute further to the community. | |||||||||
9 | Lin Wang, 王琳 | since 2023 | 2023 summer BBQ, 2023 biopacific conference, 2024 investor forum | Director, Gilead Sciences | https://www.linkedin.com/in/lin-wang-207b7836/ | Lin got her PhD in Analytical Chemistry from University of Florida. Following that, she has been a CMC analytical lead with >16 years of pharmaceutical drug development experience at Eli Lilly, Merck, and Gilead for small molecule and polypeptide spanning from lead optimization to commercialization in various dosage forms including combination products with up to four actives. She also led diversity program activities and earned corporate President’s Diversity Awards, and organized offsite cross-functional PR&D worldwide meeting etc. Lin has >40 peer-reviewed research publications and one patent. | I’d like to learn and collaborate with other CABS EC members, leverage my pharmaceutical development experience and organizational skills to promote business & career development (BAC) and entrepreneur-club (E-Club) for professionals in the biopharmaceutical industry. | |||||||||
10 | Jack Zhu - 朱宁 | 2.5 years | BCD | Associate Director, Sales analytics, Gilead | https://www.linkedin.com/in/jack-zhu-69452b98/ | I am currently associate director at Gilead in commercial analytics. Before Gilead, I worked for several CDMO and CRO covering cell and gene therapy, preclinical testing, and gene sequencing, etc. My past career gives me analytical skills and front-end customer facing experience. I want to leverage my skillset to contribute to CABS development and service broader community. | I joined CABS EC in late 2021 and served in BCD. I devoted majority my time in the flagship program CAN, which connects people who want to serve as mentors and who want to learn as mentees. During the two years, I worked with CAN team to increase the registration number by 50% and the program received very positive reputation. Through this opportunity, I gained a good understanding of how the non-profit event works and how CABS works, and got to know lots of professionals in biotech industry. I want to leverage my knowledge, experience, and network to continue work for CABS and contribute to our community. | |||||||||
11 | Liping Meng - 孟利平 | 12 years | Serving in CABS committees since 2011, including as Co-chair of Membership Committee 2015-2017 and Co-chair of Business and Career Development Committee 2018-present. | SRS II, Gilead Sciences | https://www.linkedin.com/in/liping-meng | Liping currently holds the position of Senior Scientist II at Gilead Sciences, bringing forth over 15 years of managerial expertise in pharmaceutical and biotech sectors, spanning research, production, and analytical CMC. Her successful oversight encompasses more than 20 drug development projects, guiding them from initial stages to commercialization. Notably, she played a pivotal role in the regulatory journey of Sunlenca® (lenacapavir), culminating in FDA approval as a groundbreaking, twice-yearly treatment for individuals with multi-drug resistant HIV. Before her current role, Liping held a leadership position at AnaSpec. Prior to that, she engaged in research at UC Davis following the completion of her doctoral degree in Organic Chemistry from the University of Tuebingen, Germany. Beyond her professional endeavors, Liping has dedicated substantial volunteer hours to CABS for over a decade. Throughout these years, she has actively participated in organizing various CABS events, including the annual BioPacific Conferences, CABS job fairs, career development series, and the annual Career Advisory Network (CAN) program. Her commitment and excellence have been recognized through multiple awards from CABS, including Outstanding Service Awards and Co-Chair Contribution Awards. | With over a decade of volunteer experience at CABS, I am excited to observe the community's remarkable growth and the diverse and impactful services it offers to the biopharmaceutical society. Being a proud member, I am enthusiastic about contributing to the community's development and the provision of valuable services. “As we work to create light for others, we naturally light our own way.” In this election, I am eager to seize the opportunity to further establish a robust platform for CABS members, engage with our community, and make significant contributions to the continued growth of CABS. | |||||||||
12 | Bing (Vivian) Liu-刘冰 | 2 years | MEM | Lab Director | https://www.linkedin.com/in/bing-liu-4a9172ab/?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app | My name is Vivian Liu, lab director of Novogene. I relocated in US to lead a new lab start-up in bay area in 2022 and took care of operations of single cell service. Previously, I participated in product development of NGS-based companion diagnostics in China. Also, I was serving as co-chair of membership community of CABS in 2023 and was in charge of volunteer arrangement of 2023 BioPacific conference | Optimize the protocol and trackable record we have to the next generation. | |||||||||
13 | Crystal Tan | 1 year | STC | Nurse at Ophthalmology, San Francisco General Hospital | https://www.linkedin.com/in/crystal-tan-50b075168/ | Crystal Tan is working in Ophthalmology, San Francisco General Hospital | With over 10 years of experience as a nurse in the Ophthalmology Department at San Francisco General Hospital, I believe I can lend my expertise in patient care and medical administration to serve on the Executive Committee of CABS and help advance the mission of promoting Chinese-American professionals | |||||||||
14 | Lifei (Alex) Yang - 杨立飞 | 1.5 year | 2023 STC CoChair and EC member Volunteer for CABS since 2022 | STC, BCD | Senior Scientist, Vir Biotechnology | www.linkedin.com/in/lifei-yang | Alex Yang has served as Senior Scientist of Vir since November 2021. In this role, Dr. Yang is leading and participating multiple research projects. Dr. Yang has more than 11 years of in-depth immunology research and development experience, focusing on the development of vaccine, antibody and cell therapies against infectious diseases, immune oncology and autoimmune diseases. Prior to joining Vir, Dr. Yang worked at the Scripps Research Institute, Staidson Biopharma and Nkarta. Dr. Yang received his B.S. from East China University of Science and Technology, and Ph.D. from the Institute Pasteur of Shanghai, Chinese Academy of Sciences. Dr. Yang did his postdoctoral studies at the University of Washington and the Scripps Research Institute. | I would like to continue to serve CABS and the community. | ||||||||
15 | Denna Kwang - 鄺玉丹 | 1.5 years | AMC, PRC | AMC | Senior Associate Scientist, Johnson & Johnson | www.linkedin.com/in/denna-kwang | Denna was graduated from University of California, Berkeley in 2017 with microbial biology major. She has more than 6 years of research experience in multiple biopharmaceutical fields, such as protein crystallography, molecular biology, and immune-oncology with proven accomplishments with publications, model characterizations, and screening the candidate drugs to move forward for IND filing. Along with various projects, she has working experiences in both academic and industrial settings. She is currently working at Johnson and Johnson Innovative Medicine as a Senior Associate Scientist in gene therapy department. Denna is a science-driven, strongly independent, and motivated researcher who eager to provide better healthcare by seeking the undiscovered therapeutics with integrity and creativity. Denna has been actively volunteering in CABS for over a year. | I nominate myself as EC member for AMC . I joined the CABS community since August 2022. Since then, I have been actively participated in PRC in which I have been accountable for cross-promotion between media partners. After 2023 EC election, I joined as EC member in AMC (mainly responsible for gold sponsorship for annual conference), and served as “lunch and learn” session chair, backstage/logistics crew, check-ins, and many more. Apart from responsibilities of AMC, I am also actively involved as event volunteer in multiple CABS events. During my term as EC/co-chair at AMC, I would like to engage more with people from vendors and sponsors. Moreover, I will try to improve the workflow of sponsorship. Depend on the workload and accessibility, I would like to plan in advance for sponsorship for other CABS events and activities in addition to annual conference. I believe that my background and passion will make me a valuable asset to the AMC as well as CABS. | ||||||||
16 | Yan Wang | 5 years | PRC, STC | STC | Director @ChemPartner | https://www.linkedin.com/in/yan-wang-a427482b/ | Current company: ChemPartner-SF Site | My volunteer experience at CABS has been great. It is a well-established non-profit organization holding high-quality activities in the Bay area for 25 years. You could learn many things here: project management, leadership, public speaking, etc. I volunteered at STC for two years. I learned how to organize scientific seminars and workshops. All the volunteers supported any event they could across different committees. I’d love to continue to work together with the CABS team for more great activities in 2024. | ||||||||
17 | Jonathan Wong | I was invited to speak at a meeting, regarding recruitment and how to navigate when searching for a new job at a biotech. Other than that, I have only attended CABS events. | No service prior. | Business and Career Development | Member of CABS and interested in serice | https://www.linkedin.com/in/jonwings/ | I am an American born Chinese man with blue collar, immigrant parents that worked hard to make a comfortable life for my sister and I here in the states. I received my Bachelor's degree from The University of CA, Los Angeles and started working in the Biotech / Life Sciences space in 2010, specifically as a head of Talent Acquisition. I quickly fell in love with the industry as it was my way to contribute to curing and treating those that were sick. I may not be the physician leading the clinical trials or the Scientist finding the next molecule to treat a form of cancer, but I can assist those individuals in finding the best company for them to thrive. I finally started my own recruitment practice back in 2022 and now have the freedom to serve many biotechs versus the single one I worked for. I am proud to serve others as a minority entrepreneur. | It would be an honor and privilege to be selected to the Executive Counsel for CABS. If selected I would serve with a volunteers heart and help to uplift and help my fellow ethnic Chinese colleagues excel in their careers and well being. In a country where we need to still fight daily for opportunities we have worked hard for, it is very important we watch out for one another and promote each other versus bringing each other down and competing in toxic ways. I plan on bringing a fresh perspective as someone who is deeply rooted in his Chinese tradition but was born and raised here in the United States and understands the landscape we are in. I gratefully submit my application for consideration. Thank you! | ||||||||
18 | Mingdian Tan - 谭明典 | 1 year | BCD | SLC | Postdoc-Stanford University | https://www.linkedin.com/in/%E6%98%8E%E5%85%B8-%E8%B0%AD-623495a8/ | Mingdian Tan is a dedicated researcher and postdoctoral fellow currently at Stanford University, specializing in Hepatocellular Carcinoma (HCC) research, anti-tumor drug screening, and immune response within the tumor microenvironment. With a background in Cell Biology, Tan earned a Ph.D. from the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, focusing on hematopoietic stem cells' self-renewal and differentiation. His extensive research experience spans prestigious institutions, including Stanford University, UC Berkeley, and Shanghai Tenth People's Hospital. Tan has made significant contributions to diverse areas such as Alzheimer's disease, colon cancer, and diabetes-induced inflammation. Tan's expertise includes CRISPR/Cas9, in vivo techniques, histology, immunofluorescence, immunoprecipitation, and molecular cloning. He has authored multiple published articles, demonstrating his commitment to advancing scientific knowledge. Recognized for his achievements, Tan has received awards such as the Translational Research and Applied Medicine (TRAM) Award at Stanford University. He also holds scientific appointments in professional associations and actively contributes to volunteer work, showcasing his leadership and community engagement. | Dear Members of the Chinese American Biopharmaceutical Society, I am honored to express my candidacy for the Social Life Committee. Over the past year, I have been an active volunteer within our society, contributing my time and energy to various events and initiatives. Serving as a committee member has provided me with valuable insights into the needs and preferences of our diverse membership. As a dedicated volunteer, I have actively participated in organizing and attending events tailored to our community's interests. These experiences have fueled my passion for fostering a vibrant and inclusive social atmosphere within our society. If elected to the Social Life Committee, I am committed to enhancing the quality and diversity of our social events. I aim to create engaging opportunities for members to connect, share experiences, and build lasting relationships. My goal is to contribute to an environment where every member feels a sense of belonging and finds value in our community. I am grateful for the chance to continue serving our society in this capacity, and I look forward to the opportunity to contribute to the enrichment of our social life. Thank you for your consideration. Sincerely, Mingdian Tan | ||||||||
19 | Lu Lu | Over 5 years | AMC and PRC | STC or E-club | Senior Director of Business Development, MicuRx Pharmaceuticals | https://www.linkedin.com/in/lulu1013/ | Lu currently serves as Senior Director of Business Development at MicuRx Pharmaceutical, leading licensing and alliance management. Before joining MicuRx, she worked at WuXi AppTec as Senior Director of Business Development.Lu has been volunteering in CABS since 2017 and most recently as co-chair of AMC in 2023 and co-chair of PRC in 2022. | I am hoping to leverage my experience to contribute to the development of CABS and bay area life science community, to facilitate innovation, collaboration and entrepreneurship. | ||||||||
20 | Yu Yang-杨宇 | 3 years | ICC | ICC | Hanhai Silicon Valley Center | No | Master of Psychology, Chinese Academy of Sciences Current CEO of Hanhai Silicon Valley Center | I love CABS, a non-profit organization, and I hope to continue working with everyone here. | ||||||||
21 | Pengan Liu - 刘鹏安 | 0 | GenScript Biotech Global Forum | N/A | Associate Scientist II | https://www.linkedin.com/in/peng-an-liu-8006aa21b/ | My name is | I have worked in the field of immunology/biology, specializing in the development and application of antibody-drug conjugates to treat asthma, atopic dermatitis, and other diseases. I was invited by Wenjia Gu and have previously worked with Summer (Sihong) Vivan in another forum (GenScript Forum). I am very excited to join the CABS family and will do my best to serve the community | ||||||||
22 | 李昕欣 | 1 year | SLC | SLC | VP, MyBioGate | https://www.linkedin.com/in/xinxinli2015/ | Xinxin devotes herself to helping scientists and entrepreneurs in advancing their venture to commercialize innovative technologies. Prior to 2020, Xinxin has organized 10+ international conferences in the U.S. and Europe including the US China Investment and Innovation Summit and the China Focus Partnering Conferences. Xinxin obtained her B.S in Chemistry from Peking University and MSPH from University of North Carolina Chapel Hill. In her free time, Xinxin enjoys sport climbing and traveling. | I enjoy meeting new people and organizing events. Making new friends and having fun are as important as developing professional skills for our members. With some experience organizing BBQ and New Year Party, I'm confident and would love to help organizing more fun activities that brings our EC team and community friends together. | ||||||||
23 | Hesong Sun-孙鹤松 | 3 | STC(1 year), ICC(2 years) | ICC | VP, Humai Medical Technology | https://www.linkedin.com/in/hesongsun/ | Dr. Hesong Sun graduated from the department of Cell and Systems Biology at the University of Toronto in 2013. He worked for a Canadian biotech company called ARC Medical where he led the development of a novel polysaccharide for the treatment of fibrotic diseases. In this role, he completed CMC, preclinical studies, animal efficacy studies, an out-licensing deal and a clinical trial for this product. In 2023, he became VP R&D at Huamai Medical, a company specialized in the development of animal tissue-derived regenerative medicine products. In this role, he led the team to successfully obtain the company’s first NMPA marketing approval in 2023 for a bone regeneration implant. He previously served as the co-chair for STC and ICC, and helped organize the 2022 CABS BioPacific Conference. | I have learned a lot about the biotech industry and received a wealth of mentorship through CABS. Therefore, I would like to contribute to this community by serving as the co-chair of ICC this year. I have organized numerous CABS online, in-person, and hybrid seminars in the past 3 years and became quite familiar with the process. I would like to share this experience with other volunteers and continue to serve the community. I am currently based in Hangzhou China, and it allows me to easily connect with speakers based in Asia. | ||||||||
24 | Qing Zhang -张清 | N.A | N.A. | E-club | LDV Partners. Partner | https://www.linkedin.com/in/qing-zhang/ | Qing M.D.MBA Qing’s first career was in the medical field, because she is passionate about helping people. When Qing started her career in venture capital in Silicon Valley, she fell in love with company-building and venture creation. She has investment experiences in biotech therapeutics, life science tools and digital healthcare. Prior to entering industry, Qing served as a physician at Singapore General Hospital. Qing earned an M.D. from Tsinghua University distinction. She did her clinical rotations at Peking Union Medical College Hospital & Brigham and Women’s Hospital and her research training at Broad Institute. She earned her MBA from Columbia Business School, where she is active in Columbia Women in Business (CWiB). | I am thrilled to present myself as a candidate for the upcoming election to lead our esteemed biotech entrepreneur group. As a dedicated member of this community, I have witnessed the incredible potential and innovation that defines our industry. It is with great enthusiasm and a deep commitment to our shared goals that I put forth my candidacy. Vision for the Group: I envision our biotech entrepreneur group as a dynamic hub of collaboration and innovation. Together, we can propel the biotech sector forward, fostering an environment where ideas flourish, partnerships thrive, and breakthroughs become the norm. My vision is rooted in the belief that by uniting our diverse expertise, we can overcome challenges and capitalize on emerging opportunities. I pledge to maintain transparent communication channels, providing regular updates on group activities, seeking your feedback, and creating opportunities for dialogue. Together, we will shape the future of our group collaboratively. | ||||||||
25 | Xinye Qian | Yes | served as a volunteer at the 2023 BioPacific Conference | Operation | Clinical Research Associate | https://www.linkedin.com/in/xinye-q-6767ab12b/ | Xinye obtained her bachelor's degree in Biochemistry from Washinton University in St.louis and just received her PhD degree in from Baylor College of Medicine with a research focus on inherited retinal diseases. | I'm Xinye and I am excited to express my sincere interest in contributing further to the CABS comunity. My experience as a volunteer during the 2023 CABS BioPacific Conference was immensely rewrading, providing me with great opportunities to connect with professionals, learn from their experiences, and gain valuable experience of event organizations. I aspire to participate in more activities and look forward to contributing to the continued success of CABS | ||||||||
26 | Huijun Zhou 周慧君 | I volunteered at CABS at its formation 20 years ago. I started to serve as the head of CABS Entrepreneurship Club 6 years ago. | CABS Entrepreneurship Club | CABS Entrepreneurship Club | Adjunct Professor, Stanford University | https://www.linkedin.com/in/huijun-ring-248606/ | Dr. Huijun Ring received her PhD in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at Stanford University School of Medicine. She is a clinical molecular geneticist and board-certified by the American Board of Medical Genetics. Dr. Ring is an experienced biotech entrepreneur and executive. Previously she worked at Incyte Pharmaceuticals and DNA Direct in Silicon Valley. She was the founder and CEO of iDNA Inc, a precision medicine company. iDNA Inc. was named as one of the fastest growing technology companies in China by Deloitte and was acquired by a public company. She has also cofounded and advised several biotech startups in Silicon Valley and mentored many first-time entrepreneurs. Currently, Dr Ring is an Adjunct Professor at Department of Medicine, Stanford University. She is involved in mentoring Stanford Graduate School of Business students, Knight-Hennessy Scholars, and junior women faculty in science and medicine through the Stanford University Faculty Development Office. She also conducts research on genomic medicine and bio-sustainability. | I would like to serve as a co-chair or as an advisor to CABS Entrepreneurship Club | ||||||||
27 | Li Wang- 王莉 | 4 years | SLC | SLC | Associate scientist, Arcus | None | I worked in the hospital for 10 years before i came to north american. I worked at Amgen for 14 years before i work at Arcus. | I was SLC co-chair for couple years. I was in charge SLC group all the major activities . I have experiences to handle SLC team works. Plus i have good communication skills and put lots of my time to host SLC activities. | ||||||||
28 | Katherine Guan | 1.25 years | Since September of 2022, I participated in events organized by CABS and served as a volunteer for the AMC and SLC. My highlighted contribution to the CABS BioPacific conference including being a timer for the seminars in 2022 and a chair for one of the two Lunch & Learn sessions in 2023. | AMC (open to other committees as needed) | Scientist II, AbbVie | http://linkedin.com/in/katherine-guan | Katherine obtained her bachelor’s degree in Biochemistry and Molecular Biology from University of California, Santa Cruz in 2014. Following her brief research experience on melanoma at UCSF, she joined Intrexon Corp. in 2015 and became an integral member on the development of high-throughput cell-based and biochemical assays for the novel Methane Bioconversion platform. Prior to her current role as a scientist in Oncology Discovery Research at AbbVie since December of 2023, Katherine was focusing on cell-based imaging assay development for anti-viral discovery in Infectious Diseases at Johnson and Johnson for three years. | I enjoyed my volunteer experience at CABS and am grateful for the opportunities to take on leadership roles and to learn from professionals with different expertise. It would be my honor to continue to serve and make more impactful contribution to the CABS community in area as needed. Thank you for your consideration! | ||||||||
29 | Ava Song - 宋雪 | 5 month | PRC | PRC | Associate Consultant - C Space | https://www.linkedin.com/in/avasong817/ | Ava is an accomplished professional with a diverse background in trade and investment, market research, and hospitality. As an Associate Consultant at C SPACE, a global market research firm specializing in financial and tech services, Ava plays a key role in the company's success. Prior to this, she made significant contributions at Pegasus Tech Ventures China, managing global portfolios and fostering international partnerships. Ava's achievements extend to her role as a Business Development Manager at the Australian Federal and State Government Trade Office, facilitating bilateral trade and investment in healthcare and infrastructure. With a Master's in Entrepreneurship and Innovation from the University of San Francisco and a Bachelor's in Hospitality Management from Griffith University in Australia, Ava possesses a dynamic skill set, making her an invaluable asset for future endeavors. | As a committee member, I am dedicated to fostering collaboration, knowledge exchange, and innovative initiatives that propel our association forward. I am eager to champion professional development, networking opportunities, and the diverse interests of our membership. | ||||||||
30 | KAIQING ZHANG | 1 year | PRC | PRC | BD Manager, Biocytogen | www.linkedin.com/in/kaiqing-zhang-b184657a | Hi, I am Kaiqing, a BD manager from Biocytogen, I am based in South SF and Germany | I enjoyed the working for CABs and look forward to grow together with all the teams | ||||||||
31 | Yuki Yang - 杨艺瑶 | 1 year and half | AMC, SLC | Open to any team | Research Associate II - Vaxart Inc | www.linkedin.com/in/yuki-yang-yy | I obtained my bachelor's degree in Clinical Nutrition from UC Davis, have been working in various field before stepped into the biotech industry in 2019. I currently working with analytical assays to analyze drug products and in process drug substance. | I enjoyed my time volunteering at CABS events and learned a lot from it. Ever since I joined CABS, I felt all the passions from other members and felt great to be influenced by them. Thou I don't have a strong background in biotech, but I would love to contribute as I can to make some positive impact to the community. | ||||||||
32 | Yang Ma 马杨 | 3 | O2 | O2 | Student | https://www.linkedin.com/in/yang-ma-869222249?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app | College Student | I enjoyed the society of CABS, love its atmosphere. Last year I learned more than what I expected! | ||||||||
33 | Yujiao Zhang - 张玉娇 | N/A | N/A | PRC or STC | Business Development - KACTUS | https://www.linkedin.com/in/yujiao-zhang-phd | I am a BD professional at KACTUS, a biotech company that develops innovative materials for drug discovery and development. With a PhD in Life Science, I have a strong background in immunology, cardiovascular science, and molecular and cellular biology. In my current role, I leverage my scientific expertise and communication skills to create and deliver engaging marketing content, support product launches, and build strategic partnerships with key stakeholders in the biopharmaceutical industry. Previously, I was an Account Manager at BGI Genomics, where I managed NGS projects and established long-term collaborations with customers in France. I also have four years of experience as a Doctoral Researcher at Inserm, where I led a pre-clinical project on the role of an immune-related protein in atherosclerosis. and published my findings in Nature Communications. I am passionate about bridging the gap between scientific research and clinical practice, and I enjoy working in a dynamic and collaborative environment. | Having spent 13 years in France, it was only last year that I ventured into the hub of the biotech world - the Bay Area. This dynamic shift in my life swiftly led me to CABS. The experience as a sponsor at the CABS 2023 Annual Conference reinforced my desire to join this remarkable family, to broaden my connections, and to expediently deepen my understanding of the local biopharmaceutical landscape. My background is solidly rooted in the biotech industry, complemented by a rich understanding of European culture. I am fluent in three languages - French, English, and Chinese - an asset I believe is valuable in our increasingly globalized world. Additionally, I am an influencer with a strong following of over 570,000 followers. This experience has honed my skills in content creation and effective communication, making me well-equipped to contribute meaningfully to CABS. I am eager to bring my unique blend of professional expertise, cultural insight, and communication skills to CABS. I hope my application is met with favorable consideration, as I look forward to the opportunity to contribute to and grow with this esteemed organization. | ||||||||
34 | Zhiqing Wang - 汪志晴 | < 1 year | Scientist, Metagenomi | http://linkedin.com/in/zhiqing-wang-5a95b568 | Zhiqing Wang obtained her PhD in Chemical Engineering from University of Houston. Her research focuses on biocatalysis and protein engineering. After graduation, she spent 5 years working on the engineering and manufacturing of industrial and food enzymes. She is currently a scientist at Metagenomi, working on building automated protein engineering workflow in human cells. | Collaboration and iteration is how we come up with powerful solutions together. | ||||||||||
35 | Danielle Liu - 刘丹 | 2 years | YES | BCD | Head of HR, Socrates Global, and Founder of Jiusheng Consulting Firm | https://www.linkedin.com/in/liu-dan-danielle-a5616018/ | With over 20 years of experience in transnational human resource management across various industries, Danielle has played a key role in upgrading internal human resources operations for Chinese pharmaceutical and biopharmaceutical companies. She has led teams in establishing and integrating business development, R&D, and clinical research teams in China and the United States. Danielle's career highlights include Head of HR in Socrates Global (Web3), contributing to the success of Vcredit Group's listing on the Hong Kong Stock Market in 2018, and holding key HR positions at Home Depot, Deutsche Bank China, Eli Lilly, and Merck. A graduate of the China Europe International Business School (CEIBS) with an MBA, Beyond her professional accomplishments, Danielle is a dedicated mother of three, passionate about family, friends, travel, and actively engages in volunteer work supporting the career development of new college graduates. | After dedicating two years as a volunteer within CABS, I am excited to being the candidacy for the position of EC again. Serving as a volunteer has provided me with valuable insights into the dynamics and needs of our community. I expected to leverage this experience and bring a fresh perspective continuedly to the organization. My commitment to CABS runs deep, and I see the role of EC as an opportunity to contribute in a different capacity. I enjoyed the time to work with the people of CABS very much. | ||||||||
36 | Le Cai - 蔡乐 | < 1 year | N/A | N/A | Scientist, A&P Inphatec | https://www.linkedin.com/in/le-cai-60962011a/ | Dr. Le Cai got her bachelor's degree from Peking University in 2013 and then earned her Ph.D. in Biology from Stanford University in 2020. After finishing her studies, she became an R&D Scientist in the biotech industry in the Bay Area, working on assay development, cell biology and IVD products. Le is passionate on bridging science and practical solutions in the biomedical industry. | I echo CABS's goal for promoting collaboration among Chinese biopharmaceutical professionals and enhancing their career development. I'd love to join, serve, and contribute to the CABS community. | ||||||||
37 | ||||||||||||||||
38 | ||||||||||||||||
39 | ||||||||||||||||
40 | ||||||||||||||||
41 | ||||||||||||||||
42 | ||||||||||||||||
43 | ||||||||||||||||
44 | ||||||||||||||||
45 | ||||||||||||||||
46 | ||||||||||||||||
47 | ||||||||||||||||
48 | ||||||||||||||||
49 | ||||||||||||||||
50 | ||||||||||||||||
51 | ||||||||||||||||
52 | ||||||||||||||||
53 | ||||||||||||||||
54 | ||||||||||||||||
55 | ||||||||||||||||
56 | ||||||||||||||||
57 | ||||||||||||||||
58 | ||||||||||||||||
59 | ||||||||||||||||
60 | ||||||||||||||||
61 | ||||||||||||||||
62 | ||||||||||||||||
63 | ||||||||||||||||
64 | ||||||||||||||||
65 | ||||||||||||||||
66 | ||||||||||||||||
67 | ||||||||||||||||
68 | ||||||||||||||||
69 | ||||||||||||||||
70 | ||||||||||||||||
71 | ||||||||||||||||
72 | ||||||||||||||||
73 | ||||||||||||||||
74 | ||||||||||||||||
75 | ||||||||||||||||
76 | ||||||||||||||||
77 | ||||||||||||||||
78 | ||||||||||||||||
79 | ||||||||||||||||
80 | ||||||||||||||||
81 | ||||||||||||||||
82 | ||||||||||||||||
83 | ||||||||||||||||
84 | ||||||||||||||||
85 | ||||||||||||||||
86 | ||||||||||||||||
87 | ||||||||||||||||
88 | ||||||||||||||||
89 | ||||||||||||||||
90 | ||||||||||||||||
91 | ||||||||||||||||
92 | ||||||||||||||||
93 | ||||||||||||||||
94 | ||||||||||||||||
95 | ||||||||||||||||
96 | ||||||||||||||||
97 | ||||||||||||||||
98 | ||||||||||||||||
99 | ||||||||||||||||
100 |